BANK OF MONTREAL /CAN/ - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$76,236,000
+39.9%
3,280,349
-4.2%
0.06%
+28.6%
Q1 2018$54,506,000
-27.3%
3,423,747
-5.2%
0.05%
-24.6%
Q4 2017$75,021,000
-13.8%
3,610,256
-40.6%
0.06%
-18.8%
Q3 2017$87,080,000
-20.5%
6,076,751
-4.0%
0.08%
-23.8%
Q2 2017$109,521,000
+46.5%
6,330,670
-6.6%
0.10%
+47.9%
Q1 2017$74,768,000
+3.3%
6,778,655
+47.9%
0.07%
-6.6%
Q4 2016$72,386,000
-15.5%
4,584,195
+31.4%
0.08%
-18.3%
Q3 2016$85,625,000
+22.8%
3,487,756
+0.7%
0.09%
+17.7%
Q2 2016$69,726,000
-63.3%
3,462,030
-52.1%
0.08%
-61.1%
Q1 2016$190,030,000
-51.7%
7,225,456
+86.5%
0.20%
-56.8%
Q4 2015$393,769,000
-65.7%
3,873,765
-39.8%
0.47%
-70.4%
Q3 2015$1,147,427,000
-32.5%
6,432,479
-15.9%
1.59%
-20.3%
Q2 2015$1,699,545,000
+16.8%
7,650,431
+4.5%
1.99%
+18.2%
Q1 2015$1,454,497,000
+41.6%
7,323,012
+2.0%
1.68%
+44.8%
Q4 2014$1,027,046,000
+3.8%
7,176,612
-4.9%
1.16%
+3.8%
Q3 2014$989,745,000
+0.9%
7,543,784
-3.0%
1.12%
+2.3%
Q2 2014$981,189,000
-7.1%
7,779,802
-2.8%
1.10%
-19.5%
Q1 2014$1,055,626,000
+81.2%
8,007,479
+61.4%
1.36%
+70.9%
Q4 2013$582,512,000
+11.7%
4,961,778
-0.7%
0.80%
-1.6%
Q3 2013$521,529,000
+30.8%
4,998,844
+7.9%
0.81%
+14.6%
Q2 2013$398,759,0004,632,4300.71%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2017
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders